Keywords: novartis, trileptal, gets, new, use, oked, usa

Novartis' Trileptal gets new use OKed in USA

Article | 18 August 2003

The US Food and Drug Administration has granted marketing clearance for Novartis' Trileptal (oxcarbazepine) tablets and oral suspension for use ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Go to company listing

Related Drugs

Oxcarbazepine

Trileptal

Nystatin

Go to drug listing